Profile Picture
Bob Littauer
Bob’s 35-year career as a senior financial and operational executive spans the biopharmaceutical, medical device and Internet service sectors, where his leadership experience includes initial public offerings, secondary public financings and private financings, public company Audit Committee Chairman and restructurings.

At A Glance

  • CFO, CEO, Board member
  • Public company Audit Committee Chairman
  • Led two successful IPO’s and a third through road show completion
  • Financing for public and private companies, both equity and debt
  • Extensive dealings with investment bankers, research analysts and institutional investors
  • Established/managed accounting function for public and private companies
  • Extensive biopharmaceutical company experience
  • Corporate partnering and licensing transactions
  • Managed investor relations, IT, SEC reporting, legal affairs, HR
  • Corporate governance leadership

Key Leadership Accomplishments

  • Led three initial public offerings as CFO
  • Completed numerous venture capital equity and convertible debenture financings

Bio

Bob Littauer’s 35-year career as a senior financial and operational executive spans the biopharmaceutical, medical device and Internet service sectors, where his leadership experience includes initial public offerings, secondary public financings and private financings, public company Audit Committee Chairman and restructurings. His executive roles have been in venture capital portfolio companies and in publicly owned companies. He is currently working part-time as CFO of Light Sciences Oncology, Inc., a development stage company focused on oncology and urology. Other major assignments included CFO of Avenue A (subsequently renamed aQuantive), a digital marketing service and technology company, Sr. VP and CFO of Ostex International, a biopharmaceutical company focused on products for the management of osteoporosis and Sr. VP and CFO of Poniard Pharmaceuticals, Inc., a biopharmaceutical company developing cancer therapeutics. He holds a BS in Industrial Engineering/Operations Research and an MBA in Finance, both from Cornell University.